Intervention 1: Intervention group: Intervention group will receive one tablet of test product (Primidone tablet of Ashbal Shimi, Iran) in fasted state. Blood samples will be collected for 72 hours at

2 trials

Sponsors

Tabriz University of Medical Sciences

Conditions

In the present study, the products will be administered to healthy volunteers..

Phase 1

In vivo Bioequivalence study of Primidone tablet

RecruitingIRCT20220211053992N43

Tabriz University of Medical SciencesIn the present study, the products will be administered to healthy volunteers..

Start: 2024-10-16Target: 24Updated: 2025-01-08

In vivo Bioequivalence study of Primidone tablet

RecruitingIRCT20220211053992N46

Tabriz University of Medical SciencesIn the present study, the products will be administered to healthy volunteers..

Start: 2025-04-05Target: 24Updated: 2025-07-21